Renaissance Technologies’s Oruka Therapeutics, Inc. Common Stock ORKA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$156K Sell
13,900
-21,900
-61% -$245K ﹤0.01% 3215
2025
Q1
$367K Buy
+35,800
New +$367K ﹤0.01% 2854
2024
Q3
Sell
-6,092
Closed -$280K 3962
2024
Q2
$280K Buy
6,092
+617
+11% +$28.4K ﹤0.01% 2933
2024
Q1
$116K Buy
5,475
+700
+15% +$14.8K ﹤0.01% 3342
2023
Q4
$97K Buy
4,775
+542
+13% +$11K ﹤0.01% 3311
2023
Q3
$102K Buy
4,233
+525
+14% +$12.7K ﹤0.01% 3238
2023
Q2
$90K Buy
3,708
+400
+12% +$9.71K ﹤0.01% 3502
2023
Q1
$79K Buy
3,308
+375
+13% +$8.96K ﹤0.01% 3559
2022
Q4
$83K Buy
2,933
+141
+5% +$3.99K ﹤0.01% 3681
2022
Q3
$69K Buy
2,792
+84
+3% +$2.08K ﹤0.01% 3683
2022
Q2
$81K Buy
+2,708
New +$81K ﹤0.01% 3899
2021
Q1
Sell
-17,125
Closed -$824K 3782
2020
Q4
$824K Buy
17,125
+13,932
+436% +$670K ﹤0.01% 2602
2020
Q3
$169K Sell
3,193
-3,664
-53% -$194K ﹤0.01% 3140
2020
Q2
$545K Sell
6,857
-4,251
-38% -$338K ﹤0.01% 2844
2020
Q1
$372K Sell
11,108
-773
-7% -$25.9K ﹤0.01% 2894
2019
Q4
$814K Buy
11,881
+3,540
+42% +$243K ﹤0.01% 2720
2019
Q3
$535K Buy
8,341
+1,634
+24% +$105K ﹤0.01% 2849
2019
Q2
$589K Buy
6,707
+2,533
+61% +$222K ﹤0.01% 2927
2019
Q1
$337K Buy
4,174
+384
+10% +$31K ﹤0.01% 3055
2018
Q4
$273K Buy
3,790
+686
+22% +$49.4K ﹤0.01% 3056
2018
Q3
$375K Buy
3,104
+1,163
+60% +$141K ﹤0.01% 2939
2018
Q2
$233K Sell
1,941
-529
-21% -$63.5K ﹤0.01% 3039
2018
Q1
$266K Buy
2,470
+1,870
+312% +$201K ﹤0.01% 3114
2017
Q4
$175K Sell
600
-496
-45% -$145K ﹤0.01% 3158
2017
Q3
$272K Buy
1,096
+844
+335% +$209K ﹤0.01% 2930
2017
Q2
$130K Buy
252
+110
+77% +$56.7K ﹤0.01% 3056
2017
Q1
$78K Buy
142
+53
+60% +$29.1K ﹤0.01% 3104
2016
Q4
$55K Buy
+89
New +$55K ﹤0.01% 3160
2014
Q1
Sell
-407
Closed -$1.03M 3045
2013
Q4
$1.03M Buy
407
+345
+556% +$876K ﹤0.01% 2058
2013
Q3
$150K Buy
62
+52
+520% +$126K ﹤0.01% 2636
2013
Q2
$19K Buy
+10
New +$19K ﹤0.01% 2739